AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 291: E947-E951, 2006. First published June 13, 2006; doi:10.1152/ajpendo.00128.2006
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/E947    most recent
00128.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lomenick, J. P.
Right arrow Articles by Handwerger, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lomenick, J. P.
Right arrow Articles by Handwerger, S.

Transcription factor FOXF1 regulates growth hormone variant gene expression

Jefferson P. Lomenick, Michael A. Hubert, and Stuart Handwerger

Department of Pediatrics, University of Cincinnati College of Medicine, and Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Submitted 21 March 2006 ; accepted in final form 7 June 2006

Deletion analysis of the human growth hormone variant (GHV) promoter in transient transfection studies in BeWo choriocarcinoma and HepG2 cells indicated that the region extending from nt –158/+57 retained full transcriptional activity. DNase I footprint analysis of the fragment revealed a protected region at nt –82/–77, which is in a putative FOXF1/FOXF2 binding site. Supershift assays using an antiserum to human FOXF1 demonstrated that the protected region binds FOXF1. Overexpression of FOXF1 in BeWo and HepG2 cells induced the GHV promoter, whereas overexpression of FOXF2 was without effect. Mutagenesis of the FOXF1/FOXF2 site reduced basal promoter activity by 50–60% and markedly attenuated transactivation of the promoter by FOXF1. These studies indicate that FOXF1 induces GHV expression by interaction with a FOXF1/FOXF2 cis-element in the proximal promoter.

forkhead box F1; placenta; transcription; promoter activity



Address for reprint requests and other correspondence: J. P. Lomenick, Dept. of Pediatrics, Kentucky Clinic J463, Univ. of Kentucky College of Medicine, 740 South Limestone, Lexington, KY 40536 (email: jplome2{at}email.uky.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.